| DB ID | MyCo_7247 |
| Title | A case of aspergillosis associated with intralobar pulmonary sequestration |
| Year | 2011 |
| PMID | 21357323 |
| Fungal Diseases involved | Pulmonary aspergillosis |
| Associated Medical Condition | intralobar pulmonary sequestration |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Serum tumor marker CA 19-9 |
| Biomarker Full Name | Serum tumor marker CA 19-9 (carbohydrate antigen) |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | A 32-year-old man was admitted with complaints of blood-stained sputum. |
| Cohort No. | 1 |
| Age Group | 32 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | Pulmonary aspergillosis (PA) generally results from the colonization of a pre-existing lung cavity or of a bronchiectatic lesion by the ubiquitous Aspergillus fungi species. PA often requires surgical intervention when there is a risk of sudden life-threatening hemop- tysis or when antifungal agents are not effective. |
| Technique | None |
| Analysis Method | None |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | None |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
| External Link | None |
